Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention

por Shanmuganathan, Naranie, Wadham, Carol, Shahrin, NurHezrin, Feng, Jinghua, Thomson, Daniel, Wang, Paul, Saunders, Verity, Kok, Chung Hoow, King, Rob M., Kenyon, Rosalie R., Lin, Ming, Pagani, Ilaria S., Ross, David M., Yong, Agnes S.M., Grigg, Andrew P., Mills, Anthony K., Schwarer, Anthony P., Braley, Jodi, Altamura, Haley, Yeung, David T., Scott, Hamish S., Schreiber, Andreas W., Hughes, Timothy P., Branford, Susan
Publicado 2023

Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance

por Barraclough, Allison, England, James T., Villa, Diego, Wight, Joel, Hapgood, Greg, Conn, Jason, Doo, Nicole Wong, Li, Eric Wenlong, Gilbertson, Michael, Shaw, Briony, Bishton, Mark J., Saeed, Malik, Ratnasingam, Sumita, Abeyakoon, Chathuri, Chong, Geoff, Wai, Shin Hnin, Ku, Matthew, Lee, Hui-Peng, Fleming, Kathryn, Tam, Constantine, Douglas, Genevieve, Cheah, Chan Y., Ng, Zi Yun, Rolfe, Tukten, Mills, Anthony K., Hamad, Nada, Cashman, Helen, Gleeson, Mary, Narayana, Manjunath, Hawkes, Eliza A.
Publicado 2023